Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Thompson

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Journal of Medicinal Chemistry|July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> ActivityMichael G Thomas, Manu De Rycker, Richard J Wall, et al.
Journal of Medicinal Chemistry|June 21, 2023
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of AnaloguesLaura A T Cleghorn, Richard J Wall, Sébastien Albrecht, et al.
Journal of Medicinal Chemistry|April 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral LeishmaniasisMichael Thomas, Stephen Brand, Manu De Rycker, et al.
Journal of Medicinal Chemistry|November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasisStephen Brand, Neil R Norcross, Stephen Thompson, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
RSC Medicinal Chemistry|January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Medicinal Research Reviews|December 14, 2004
Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targetsJustine Y Q Lai, Steven Langston, Ruth Adams, et al.
Journal of Medicinal Chemistry|August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziStephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Journal of Medicinal Chemistry|December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral LeishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Journal of Medicinal Chemistry|July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> ActivityMichael G Thomas, Manu De Rycker, Richard J Wall, et al.
Journal of Medicinal Chemistry|June 21, 2023
Development of a 2,4-Diaminothiazole Series for the Treatment of Human African Trypanosomiasis Highlights the Importance of Static-Cidal Screening of AnaloguesLaura A T Cleghorn, Richard J Wall, Sébastien Albrecht, et al.
Journal of Medicinal Chemistry|April 27, 2021
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral LeishmaniasisMichael Thomas, Stephen Brand, Manu De Rycker, et al.
Journal of Medicinal Chemistry|November 21, 2014
Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasisStephen Brand, Neil R Norcross, Stephen Thompson, et al.
ACS Infectious Diseases|February 27, 2025
Identification of a Series Containing a Pentafluorophenyl Moiety That Targets Pks13 to Inhibit Growth of <i>Mycobacterium tuberculosis</i>Simon R Green, Justin R Harrison, Stephen Thompson, et al.
RSC Medicinal Chemistry|January 22, 2021
Identification of 6-amino-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidines with <i>in vivo</i> efficacy against visceral leishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Medicinal Research Reviews|December 14, 2004
Preparation of kinase-biased compounds in the search for lead inhibitors of kinase targetsJustine Y Q Lai, Steven Langston, Ruth Adams, et al.
Journal of Medicinal Chemistry|August 29, 2017
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruziStephen Brand, Eun Jung Ko, Elisabet Viayna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Journal of Medicinal Chemistry|December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral LeishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Pageof 14